A carregar...
Efficacy of Switching From Teriparatide to Bisphosphonate or Denosumab: A Prospective, Randomized, Open‐Label Trial
There is no consensus on an optimal treatment after daily teriparatide (TPTD). We performed a prospective, randomized, open‐label, 12‐month trial to investigate the efficacy of follow‐up treatment after daily TPTD treatment for Japanese patients. Three‐hundred patients were enrolled in this study. P...
Na minha lista:
| Publicado no: | JBMR Plus |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6139701/ https://ncbi.nlm.nih.gov/pubmed/30283910 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jbm4.10054 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|